Product NDC: | 59630-309 |
Proprietary Name: | Doribax |
Non Proprietary Name: | doripenem |
Active Ingredient(s): | 250 mg/10mL & nbsp; doripenem |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59630-309 |
Labeler Name: | Shionogi Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022106 |
Marketing Category: | NDA |
Start Marketing Date: | 20101015 |
Package NDC: | 59630-309-25 |
Package Description: | 48 CASE in 1 CONTAINER (59630-309-25) > 228 VIAL, SINGLE-USE in 1 CASE > 10 mL in 1 VIAL, SINGLE-USE (59630-309-01) |
NDC Code | 59630-309-25 |
Proprietary Name | Doribax |
Package Description | 48 CASE in 1 CONTAINER (59630-309-25) > 228 VIAL, SINGLE-USE in 1 CASE > 10 mL in 1 VIAL, SINGLE-USE (59630-309-01) |
Product NDC | 59630-309 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | doripenem |
Dosage Form Name | POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101015 |
Marketing Category Name | NDA |
Labeler Name | Shionogi Inc. |
Substance Name | DORIPENEM |
Strength Number | 250 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC] |